. . . "Perhaps the final irony of the Brief???s argumentation and constant citation of the Prometheus decision (???passim???) is that ???[t]hrough its patents, Myriad not only commands the law of nature that is embodied by the BRCA genes, but also laws of nature??? [A]s to how the genes might be linked to diseases other than breast and ovarian cancer ??? key scientific insights required for the developme" . .